WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ:BBLG), a developer of orthobiologic products for spine fusion, announced the pricing of an underwritten public offering of 3,777,778 units at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 before deducting underwriting discounts and commissions and other offering expenses.
Tesla’s Record Q2 Deliveries Will Send ‘Bears Into Hibernation,’ Says Analyst: 2 Reasons For The Outperformance
New data from Tesla, Inc. (NASDAQ:TSLA) will send “bears into hibernation mode,” one analyst says, citing the car…
